Skip to main content

Advertisement

Log in

Increased Sedation Requirements During Endoscopy in Patients with Celiac Disease

  • Original Article
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

Background

Celiac disease (CD) is associated with increased rates of neuropsychiatric disease and irritable bowel syndrome, and patients may exhibit visceral hypersensitivity.

Aim

The purpose of this study was to determine whether patients with CD have increased sedation requirements during endoscopic procedures.

Methods

In this retrospective cohort study, we identified CD patients undergoing either a colonoscopy or esophagogastroduodenoscopy (EGD), but not a dual procedure. CD patients were matched with control patients according to age, gender and endoscopist. For sedation requirements we defined “high” as falling outside of the 75th percentile of the entire cohort.

Results

In the colonoscopy analysis we identified 113 CD patients and 278 controls. In the CD group, 29 individuals (26%) required high amounts of both opioids and midazolam, as compared to 46 (17%) controls (P = 0.05). Differences were similar when considering only opioids (P = 0.06) and midazolam (P = 0.06). In the EGD analysis we identified 314 CD patients and 314 controls who met the inclusion criteria. Among the CD patients, 70 (22%) required high amounts of both opioids and midazolam compared to 51 (16%) controls (P = 0.05). Differences were similar when considering only opioids (P = 0.06) and midazolam (P = 0.04).

Conclusions

Patients with CD require higher doses of sedation during upper and lower endoscopy compared to age and gender-matched controls. Putative explanations, such as visceral hypersensitivity, chronic opioid/anxiolytic use, or underlying neuropsychiatric illness, should be evaluated prospectively.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Green PH, Cellier C. Celiac disease. New Engl J Med. 2007;357:1731–1743.

    Article  PubMed  CAS  Google Scholar 

  2. O’Leary C, Wieneke P, Buckley S, et al. Celiac disease and irritable bowel-type symptoms. Am J Gastroenterol. 2002;97:1463–1467.

    Article  PubMed  Google Scholar 

  3. Mulak A, Waszczuk E, Paradowski L. Anorectal function and visceral hypersensitivity in celiac disease. J Clin Gastroenterol. 2010;44:e249–e252.

    Google Scholar 

  4. Sanders DS, Carter MJ, Hurlstone DP, et al. Association of adult coeliac disease with irritable bowel syndrome: a case-control study in patients fulfilling ROME II criteria referred to secondary care. Lancet. 2001;358:1504–1508.

    Article  PubMed  CAS  Google Scholar 

  5. Whitehead WE, Holtkotter B, Enck P, et al. Tolerance for rectosigmoid distention in irritable bowel syndrome. Gastroenterology. 1990;98:1187–1192.

    PubMed  CAS  Google Scholar 

  6. Hauser W, Janke KH, Klump B, Gregor M, Hinz A. Anxiety and depression in adult patients with celiac disease on a gluten-free diet. World J Gastroenterol. 2010;16:2780–2787.

    Google Scholar 

  7. Addolorato G, Stefanini GF, Capristo E, Caputo F, Gasbarrini A, Gasbarrini G. Anxiety and depression in adult untreated celiac subjects and in patients affected by inflammatory bowel disease: a personality “trait” or a reactive illness? Hepatogastroenterology. 1996;43:1513–1517.

    PubMed  CAS  Google Scholar 

  8. Kim ES, Cheon JH, Park JJ, et al. Colonoscopy as an adjunctive method for the diagnosis of irritable bowel syndrome: focus on pain perception. J Gastroenterol Hepatol. 2010;25:1232–1238.

    Article  PubMed  Google Scholar 

  9. Lebwohl B, Stavsky E, Neugut AI, Green PH. Risk of colorectal adenomas in patients with coeliac disease. Aliment Pharmacol Ther. 2010;32:1037–1043.

    Article  PubMed  CAS  Google Scholar 

  10. Equianalgesic Doses of Opioid Analgesics. Accessed at http://endoflife.northwestern.edu/pain_management/table.pdf.

  11. Chadwick VS, Chen W, Shu D, et al. Activation of the mucosal immune system in irritable bowel syndrome. Gastroenterology. 2002;122:1778–1783.

    Article  PubMed  Google Scholar 

  12. Cellier C, Cervoni JP, Patey N, et al. Gluten-free diet induces regression of T-cell activation in the rectal mucosa of patients with celiac disease. Am J Gastroenterol. 1998;93:1527–1530.

    Article  PubMed  CAS  Google Scholar 

  13. Usai P, Manca R, Cuomo R, Lai MA, Boi MF. Effect of gluten-free diet and co-morbidity of irritable bowel syndrome-type symptoms on health-related quality of life in adult coeliac patients. Dig Liver Dis. 2007;39:824–828.

    Article  PubMed  CAS  Google Scholar 

  14. Bonaz B. Visceral sensitivity perturbation integration in the brain-gut axis in functional digestive disorders. J Physiol Pharmacol. 2003;54:27–42.

    PubMed  Google Scholar 

  15. Ciacci C, Iavarone A, Mazzacca G, De Rosa A. Depressive symptoms in adult coeliac disease. Scand J Gastroenterol. 1998;33:247–250.

    Article  PubMed  CAS  Google Scholar 

  16. Dorn SD, Hernandez L, Minaya MT, et al. Psychosocial factors are more important than disease activity in determining gastrointestinal symptoms and health status in adults at a celiac disease referral center. Dig Dis Sci. 2010;55:3154–3163.

    Article  PubMed  Google Scholar 

  17. Hadjivassiliou M, Chattopadhyay AK, Davies-Jones GA, Gibson A, Grunewald RA, Lobo AJ. Neuromuscular disorder as a presenting feature of coeliac disease. J Neurol Neurosurg Psychiatry. 1997;63:770–775.

    Article  PubMed  CAS  Google Scholar 

  18. Hadjivassiliou M, Gibson A, Davies-Jones GA, Lobo AJ, Stephenson TJ, Milford-Ward A. Does cryptic gluten sensitivity play a part in neurological illness? Lancet. 1996;347:369–371.

    Article  PubMed  CAS  Google Scholar 

  19. Hadjivassiliou M, Grunewald RA, Chattopadhyay AK, et al. Clinical, radiological, neurophysiological, and neuropathological characteristics of gluten ataxia. Lancet. 1998;352:1582–1585.

    Article  PubMed  CAS  Google Scholar 

  20. Hadjivassiliou M, Grunewald RA, Lawden M, Davies-Jones GA, Powell T, Smith CM. Headache and CNS white matter abnormalities associated with gluten sensitivity. Neurology. 2001;56:385–388.

    PubMed  CAS  Google Scholar 

  21. Hadjivassiliou M, Maki M, Sanders DS, et al. Autoantibody targeting of brain and intestinal transglutaminase in gluten ataxia. Neurology. 2006;66:373–377.

    Article  PubMed  CAS  Google Scholar 

  22. Gonda TA, Khan SU, Cheng J, Lewis SK, Rubin M, Green PH. Association of intussusception and celiac disease in adults. Dig Dis Sci. 2010;55:2899–2903.

    Article  PubMed  Google Scholar 

  23. Ersoy O, Akin E, Ugras S, Buyukasik S, Selvi E, Guney G. Capsule endoscopy findings in celiac disease. Dig Dis Sci. 2009;54:825–829.

    Article  PubMed  Google Scholar 

Download references

Conflict of interest

Dr. Green is a consultant for Shire and Alba Therapeutics, and is on the Scientific Advisory Board of Alvine Pharmaceuticals.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Benjamin Lebwohl.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lebwohl, B., Hassid, B., Ludwin, S. et al. Increased Sedation Requirements During Endoscopy in Patients with Celiac Disease. Dig Dis Sci 57, 994–999 (2012). https://doi.org/10.1007/s10620-011-1959-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10620-011-1959-5

Keywords

Navigation